journal article·2024-11-05

Controlling Circular RNA Encapsulation within Extracellular Vesicles for Gene Editing and Protein Replacement

Liang Fang, Wenchao Gu, Ruoxin Li, Chaoxin Chen, Simian Cai, Sijin Luozhong, Michelle Chen, Annie Hsu, Yi-Chih Tsai, Ketaki Londhe, Shaoyi Jiang

ACS Nano· Volume 18· Issue 44
Publisher page

Abstract

Extracellular vesicles (EVs) are a population of vesicular bodies originating from cells, and EVs have been proven to have the potential to deliver different cargos, such as RNAs. However, conventional methods are not able to encapsulate long RNAs into EVs efficiently or may compromise the integrity of EVs. In this study, we have devised a strategy to encapsulate long circRNAs (>1000 nt) into EVs by harnessing the sorting mechanisms of cells. This strategy utilizes the inherent richness of circular RNAs in EVs and a genetic engineering method to increase the cytoplasmic concentration of target circRNAs, facilitating highly efficient RNA back-splicing to drive the circularization of RNAs. This allows target circRNAs to load into EVs with high efficiency. Furthermore, we demonstrate the practical applications of this strategy, showing that these circRNAs can be delivered by EVs to recipient cells for protein expression and to mice for gene editing.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Circular RNAs in diseases · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Meinig School of Biomedical Engineering

Cornell University

Department of Molecular Biology and Genetics

Smith School of Chemical and Biomolecular Engineering

Funding

Cornell University

References (38)

Show source-provided references
1. 10.1038/nrd427810.1038/nrd4278 ↗
2. 10.1016/j.biotechadv.2020.10753410.1016/j.biotechadv.2020.107534 ↗
3. 10.1177/0897190021100965010.1177/08971900211009650 ↗
4. 10.1126/science.113250510.1126/science.1132505 ↗
5. 10.3390/vaccines905045210.3390/vaccines9050452 ↗
6. 10.1016/j.biomaterials.2016.09.00610.1016/j.biomaterials.2016.09.006 ↗
7. 10.1080/15476286.2015.102027110.1080/15476286.2015.1020271 ↗
8. 10.1261/rna.048272.11410.1261/rna.048272.114 ↗
9. 10.1007/s00018-017-2688-510.1007/s00018-017-2688-5 ↗
10. 10.1016/j.molcel.2019.02.01510.1016/j.molcel.2019.02.015 ↗
11. 10.1016/j.molcel.2019.07.01610.1016/j.molcel.2019.07.016 ↗
12. 10.2217/nnm-2020-005610.2217/nnm-2020-0056 ↗
13. 10.1038/s41580-020-0251-y10.1038/s41580-020-0251-y ↗
14. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
15. 10.1038/gt.2017.810.1038/gt.2017.8 ↗
16. 10.1038/s41591-022-02061-110.1038/s41591-022-02061-1 ↗
17. 10.1016/j.biopha.2022.11348010.1016/j.biopha.2022.113480 ↗
18. 10.1016/j.ymthe.2018.05.02410.1016/j.ymthe.2018.05.024 ↗
19. 10.1016/j.febslet.2015.04.03610.1016/j.febslet.2015.04.036 ↗
20. 10.1021/acs.nanolett.1c0181710.1021/acs.nanolett.1c01817 ↗
21. 10.1016/j.cell.2009.01.04210.1016/j.cell.2009.01.042 ↗
22. 10.1038/cr.2015.8210.1038/cr.2015.82 ↗
23. 10.1080/20013078.2018.142447310.1080/20013078.2018.1424473 ↗
24. 10.1371/journal.pone.014840710.1371/journal.pone.0148407 ↗
25. 10.1161/CIRCULATIONAHA.120.04576510.1161/CIRCULATIONAHA.120.045765 ↗
26. 10.1002/advs.20220569210.1002/advs.202205692 ↗
27. 10.1016/j.omtn.2021.01.00310.1016/j.omtn.2021.01.003 ↗
28. 10.3390/cells1010267410.3390/cells10102674 ↗
29. 10.1080/15476286.2019.170854810.1080/15476286.2019.1708548 ↗
30. 10.1016/j.jconrel.2017.09.01910.1016/j.jconrel.2017.09.019 ↗
31. 10.1016/j.celrep.2022.11065110.1016/j.celrep.2022.110651 ↗
32. 10.1038/s41467-021-22126-y10.1038/s41467-021-22126-y ↗
33. 10.5625/lar.2018.34.4.14710.5625/lar.2018.34.4.147 ↗
34. 10.1371/journal.pone.008210010.1371/journal.pone.0082100 ↗
35. 10.1038/sj.onc.121077710.1038/sj.onc.1210777 ↗
36. 10.1093/nar/gkt35810.1093/nar/gkt358 ↗
37. 10.1162/1535350020040319610.1162/15353500200403196 ↗
38. 10.1039/C8NR03970D10.1039/C8NR03970D ↗